Nkarta Correlations

NKTX Stock  USD 4.26  0.26  6.50%   
The current 90-days correlation between Nkarta Inc and Monte Rosa Therapeutics is 0.41 (i.e., Very weak diversification). The correlation of Nkarta is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Nkarta Correlation With Market

Weak diversification

The correlation between Nkarta Inc and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nkarta Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Nkarta Stock

  0.64VALN Valneva SE ADRPairCorr
  0.78DYAI Dyadic InternationalPairCorr
  0.79ERNA Eterna TherapeuticsPairCorr
  0.84XFOR X4 PharmaceuticalsPairCorr
  0.76MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.9PTN Palatin TechnologiesPairCorr
  0.74INAB In8bio IncPairCorr
  0.85INKT Mink TherapeuticsPairCorr
  0.78MNMD Mind MedicinePairCorr
  0.67MOLN Molecular PartnersPairCorr
  0.64MRVI Maravai LifesciencesPairCorr
  0.82ONCT Oncternal TherapeuticsPairCorr
  0.71ABCL Abcellera BiologicsPairCorr
  0.74ABOS Acumen PharmaceuticalsPairCorr

Moving against Nkarta Stock

  0.79BMY Bristol Myers SquibbPairCorr
  0.73GNFT GenfitPairCorr
  0.67A Agilent Technologies Fiscal Year End 18th of November 2024 PairCorr
  0.66GILD Gilead SciencesPairCorr
  0.54WVE Wave Life SciencesPairCorr
  0.44ZURA Zura Bio LimitedPairCorr
  0.43LLY Eli LillyPairCorr
  0.72AMLX Amylyx PharmaceuticalsPairCorr
  0.65BNTX BioNTech SEPairCorr
  0.62TARS Tarsus PharmaceuticalsPairCorr
  0.56ABBV AbbVie IncPairCorr
  0.54ARDX ArdelyxPairCorr
  0.52APGE Apogee Therapeutics,PairCorr
  0.51TCBPW TC BioPharm plcPairCorr
  0.42SMMT Summit Therapeutics PLCPairCorr
  0.38ANNX AnnexonPairCorr
  0.38TELO Telomir Pharmaceuticals,PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BDTXSANA
ALECGBIO
BDTXPASG
PASGSANA
GBIOLYEL
PASGGBIO
  
High negative correlations   
HARPGBIO
ALECHARP
HARPPASG
HARPLYEL
TCRRSANA
HARPBDTX

Risk-Adjusted Indicators

There is a big difference between Nkarta Stock performing well and Nkarta Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nkarta's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Nkarta Corporate Management

Ralph BrandenbergerChief OfficerProfile
Nadir MahmoodChief OfficerProfile
Greg MannVice RelationsProfile
Yvonne MBAChief OfficerProfile
Alicia HagerChief SecretaryProfile
James TragerChief OfficerProfile